Systemic Lupus Erythematosus - Houston TX (Clinical Trial 3816)
|
** Please review additional "Nearby Studies" on right ----->
|
|
 |
 |
|
| City: |
|
Houston |
| State: |
|
TX |
| Zip Code: |
|
77070 |
|
|
|
|
|
|
|
|
|
|
|
|
| Study summary: |
|
A Randomized, double-blind, placebo-controlled, three-arm, parallel-group, multicenter, multinational safety and efficacy trial of 300 mg and 900 mg of Abetimus Sodium in Systemic Lupus Erythematosus (SLE) patients with a history of renal disease. |
| Qualified participants must: |
|
• Have a diagnosis of Systemic Lupus Erythematosus (SLE)
•
Have active SLE renal disease within past 4 years
•
Be 12 to 70 years of age
•
Be non-pregnant and non-lactating
•
Use adequate birth control methods during course of study
•
Be able to have weekly intravenous (IV) administration of study treatment
•
Not have active SLE renal disease within past 3 months prior to entering study
•
Not use any of the following therapies within 3 months prior to entering the study: alkylating agents, e.g., cyclophosphamide, TNF inhibitors, cyclosporine
•
Not use mycophenolate mofetil that exceeds 1000 mg/day, azathioprine that exceeds 100 mg/day, methotrexate that exceeds 10 mg/week, leflunomide that exceeds 10 mg/day within 2 months prior to entering study
•
Not use rituximab within 6 months prior to entering study
•
Not have any current abuse of drugs or alcohol |
| Participants will receive: |
|
Study medication and study treatment at no cost. Financial reimbursement will also be given for time and travel. |
| Study is available at: |
|
Dynamed Clinical Research
If you meet the above criteria and live within 100 miles of this clinic please enter your information below and click “I Am Interested In This Study” to be contacted by the study coordinator.
or
Click “View Contact Phone Number” to get the clinic’s phone number.
|
|
Phone number: |
|
|
|
|
|
|
|
|
|
|